BTNX Inc.

BTNX Inc.

BTNX Inc. is a biotechnology company and a world leader in rapid, point-of-care diagnostics. We specialize in innovation, research, development and manufacturing of advanced in-vitro diagnostic (IVD) tests for laboratories, clinics, hospitals and physicians’ offices. BTNX Inc. also develops information technology systems to manage point-of-care diagnostic test results using HL7/POCT1-A2 compliant software solutions.

Fentanyl Forensic Test Strips

Rapid Response COVID-19 (Coronavirus) Test Kits

Rapid Response COVID-19 (Coronavirus) Test Kits

Excerpt - The Rapid Response COVID-19 Test Cassette is a rapid, qualitative test for the detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasm samples, to aid in the diagnosis of COVID-19. Interpretation of test results are COVID-19 virus positive (two lines or three lines) and COVID-19 virus negative (one line). Available for research use only. CE mark and Health Canada approval pending for diagnostic use.

More Information
BTNX Rapid Response Fentanyl Test Strips

BTNX Rapid Response Fentanyl Test Strips

Excerpt - The Rapid ResponseTM Fentanyl (FYL) Forensic Test Strip is a lateral flow chromatographic immunoassay for the qualitative detection of Fentanyl/Norfentanyl in urine and liquid and powder substances. It is specific for Fentanyl screening with no significant cross reactivity to other opiates, such as Morphine and Heroin.

More Information